CEACAM5 and metabolic dysfunction-associated steatotic liver disease: They found no significant difference between CRC patients with and without NAFLD regarding the location and differentiation of tumors, carcinoembryonic antigen (CEA), and the total number of synchronous or advanced adenomas.